Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Gains from Investment Securities: 2021-2024

Historic Gains from Investment Securities for Milestone Pharmaceuticals (MIST) over the last 3 years, with Dec 2024 value amounting to -$8,000.

  • Milestone Pharmaceuticals' Gains from Investment Securities rose 35.64% to $7.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $7.9 million, marking a year-over-year increase of 35.64%. This contributed to the annual value of -$8,000 for FY2024, which is N/A change from last year.
  • Latest data reveals that Milestone Pharmaceuticals reported Gains from Investment Securities of -$8,000 as of FY2024, which was up 94.33% from -$141,000 recorded in FY2022.
  • Over the past 5 years, Milestone Pharmaceuticals' Gains from Investment Securities peaked at $5.7 million during FY2021, and registered a low of -$141,000 during FY2022.
  • For the 2-year period, Milestone Pharmaceuticals' Gains from Investment Securities averaged around -$74,500, with its median value being -$74,500 (2022).
  • Data for Milestone Pharmaceuticals' Gains from Investment Securities shows a maximum YoY plummeted of 102.45% (in 2022) over the last 5 years.
  • Yearly analysis of 3 years shows Milestone Pharmaceuticals' Gains from Investment Securities stood at $5.7 million in 2021, then crashed by 102.45% to -$141,000 in 2022, then reached -$8,000 in 2024.